Primary |
Product Used For Unknown Indication |
42.9% |
Chest Pain |
28.6% |
Angina Pectoris |
14.3% |
Drug Use For Unknown Indication |
14.3% |
|
Device Failure |
14.3% |
Drug Ineffective |
14.3% |
Hypertension |
14.3% |
Malaise |
14.3% |
Postpartum Haemorrhage |
14.3% |
Product Quality Issue |
14.3% |
Unresponsive To Stimuli |
14.3% |
|
Secondary |
Diabetes Mellitus |
11.0% |
Hypersensitivity |
9.7% |
Asthma |
8.7% |
Hypertension |
7.6% |
Drug Use For Unknown Indication |
7.2% |
Gastrooesophageal Reflux Disease |
6.6% |
Chronic Obstructive Pulmonary Disease |
5.1% |
Chest Pain |
4.2% |
Depression |
4.2% |
Migraine |
4.2% |
Arthralgia |
3.8% |
Diabetic Neuropathy |
3.8% |
Anxiety |
3.6% |
Muscle Spasms |
3.6% |
Pain |
3.6% |
Fluid Retention |
3.0% |
Hypertensive Crisis |
2.5% |
Parenteral Nutrition |
2.5% |
Product Used For Unknown Indication |
2.5% |
Pyrexia |
2.5% |
|
Memory Impairment |
34.0% |
Mesothelioma |
17.0% |
Toxic Epidermal Necrolysis |
12.8% |
Myocardial Infarction |
10.6% |
Panic Attack |
6.4% |
Muscle Spasms |
4.3% |
Pulmonary Embolism |
4.3% |
Ventricular Fibrillation |
4.3% |
Nasopharyngitis |
2.1% |
Small Cell Lung Cancer Stage Unspecified |
2.1% |
Urinary Tract Infection |
2.1% |
|
Concomitant |
Product Used For Unknown Indication |
31.8% |
Drug Use For Unknown Indication |
21.2% |
Hypertension |
9.9% |
Angina Pectoris |
5.2% |
Coronary Artery Disease |
4.2% |
Pain |
4.0% |
Cardiac Disorder |
3.5% |
Chest Pain |
2.5% |
Atrial Fibrillation |
2.0% |
Diabetes Mellitus |
2.0% |
Asthma |
1.8% |
Diagnostic Procedure |
1.6% |
Myocardial Infarction |
1.6% |
Rheumatoid Arthritis |
1.4% |
Anticoagulant Therapy |
1.3% |
Depression |
1.3% |
Cardiac Failure Congestive |
1.2% |
Cerebrovascular Accident Prophylaxis |
1.2% |
Blood Cholesterol Increased |
1.1% |
Memory Impairment |
1.1% |
|
Myocardial Infarction |
13.1% |
Vomiting |
10.7% |
Weight Decreased |
6.5% |
Hyperkalaemia |
6.0% |
Hypertensive Crisis |
5.4% |
Pain |
5.4% |
Death |
4.8% |
Pneumonia |
4.8% |
Angina Pectoris |
4.2% |
Chest Pain |
4.2% |
Dyspnoea |
4.2% |
Pulmonary Embolism |
4.2% |
Respiratory Moniliasis |
4.2% |
Hypotension |
3.6% |
Syncope |
3.6% |
Urinary Tract Infection |
3.6% |
Cerebrovascular Accident |
3.0% |
Circulatory Collapse |
3.0% |
Hyponatraemia |
3.0% |
Paralysis |
3.0% |
|